Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
Latest patent expands intellectual property protection for advanced physiological signal acquisition and processing
Covered in this story
Call it yourself
No calls on $AMIX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Autonomix Medical →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.